Dr. Reddy's Laboratories Ltd. Dr Reddy’s Laboratories has initiated voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and 40mg from the US market due to quality concerns. 0 Likes. Recalls Ranitidine Tablets and Capsules. Back in September, The Dr. Reddy’s Over-The-Counter and Specialty Rx team in Princeton used their employer supported community service time to work together to build homes for those in need. RTTNews . Dr. Reddy’s Laboratories and Aurobindo Pharma have separately initiated voluntary recalls of a drug each from the U.S. market. Dr. Reddy’s said the recalled products were available to consumers at Walgreens, Walmart, Sam’s Club, Kroger, Target, CVS and other retailers. Dr Reddy's recalls 1,752 bottles of heartburn drug in the US The ongoing Class III recall is on account of "Discolouration" and because the product contains brown pellets, USFDA said. The company initiated a voluntary recall of 2,280 bottles of Atorvastatin Calcium 40 mg 500 tablets on August 2, according to the US Food and Drug Administration(USFDA). Wholesalers, distributors, hospitals and pharmacies with an existing inventory of the lot being recalled should stop use and distribution of the product as well as quarantine the product immediately for return or replacement of all recalled products. The drug was distributed in the United States, Myanmar and Uzbekistan. Several companies, Sanofi, Dr. Reddy’s Laboratories, and Teva Pharmaceutical, have initiated voluntary recalls of ranitidine products, an anti-acid, due to possible contamination with a nitrosamine impurity, N-nitrosodimethylamine (NDMA). Dr. Reddy’s Laboratories has recalled one lot of Docetaxel injection vials, a drug used to treat cancer, the US FDA reports.. A total of 1,051 vials of Docetaxel injection 20 mg/mL has been recalled. A spokesperson for Sanofi was not immediately available for comment. Dr. Reddy’s – Recall of ranitidine • On October 23, 2019, Dr. Reddy’s announced the voluntary, consumer-level recall of prescription ranitidine due to potential contamination with N-nitrosodimethylamine (NDMA). (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.) Pharma major Dr Reddy’s Laboratories Ltd has initiated recall of 1m752 bottles of generic Esomeprazole Magnesium delayed release capsules in the US.According to … Thank you for supporting the community! This is a class-3 recall, wh Dr Reddy’s Laboratories has also notified its distributors to arrange for return of any recalled product. Vikram Reddy, MD, PhD, is the director of colorectal surgery for Yale Medicine and one of five surgeons who are board-certified specially in colorectal cancer. As per the latest Enforcement Report by the the US Food and Drug Administration (), the Hyderabad-based drug firm is voluntarily recalling 1,752 bottles (1,000 count) of 40 mg Esomeprazole Magnesium … Eighteen of the recalled lots were recalled … Dr Reddy’s recalls anti-seizure drug from the US This is the second recall since the launch of the product in August 2013. Dr Reddy's Recalls over 13,000 Bottles of Hypertension Drug- FDA Submitted by Stephanie Vaccaro on June 19, 2014 - 8:48am India's Dr Reddy's Laboratories Ltd is recalling 13,560 bottles of the high blood pressure drug metoprolol succinate in the United States after it failed a dissolution test, the U.S. Food and Drug Administration said. HYDERABAD: Dr Reddy's Laboratories has initiated voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and 40mg from the US market due to quality concerns. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries, together referred to as “Dr. Dr.Reddy's Recalls Phytonadione Injectable Emulsion Ampules . Atorvastatin is a drug that blocks the production of cholesterol and reduces its level in the blood. Dr Reddy’s joins move to issue recalls . • Dr. Reddy’s initially announced retail level recalls for prescription and OTC ranitidine in early Date: 10/30/19 On October 23, 2019, the US Food and Drug Administration (FDA) announced that Dr. Reddy’s Laboratories Ltd. was recalling all Ranitidine products with expiration dated September 2019 to June 2021 to the consumer level due to NDMA was found in certain samples of ranitidine. Q3 FY 21 Earnings Call Notification | India Customers Only: For any Dr. Reddy’s product availability related issues, please call us on 1800 425 0014 (Monday to Friday, 8AM to 6PM IST) or emailcustomerservices@drreddys.com